Rosiglitazone - GlaxoSmithKline
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by Bristol-Myers Squibb; Daiichi Sankyo Company
- Drug Class Antidementias; Antihyperglycaemics; Antipsoriatics; Small molecules; Thiazolidinediones
- Mechanism of Action Antioxidants; Peroxisome proliferator-activated receptor agonists; Peroxisome proliferator-activated receptor gamma agonists
- USA Patent Applicants WOODWARD
- USA Patents 4
- NDAs 1
- Patent Applications 4,010
Table of Contents

Disclaimer